During the projection period of 2023 to 2030, the global market for surgical stapling devices is estimated to grow at a CAGR of 7.8%. The rising number of surgical procedures, the increased usage of surgical stapling devices in bariatric surgeries, and the growing desire for minimally invasive procedures are some of the key factors driving the growth of the surgical stapling devices market in the future years. Furthermore, the need for surgical staplers has increased in a variety of surgical techniques such as laparoscopic, bariatric, endoscopic, and others. Stapling devices are employed in the majority of cases due to the increased frequency of chronic conditions such as obesity or even sports-related injuries/arthritis operations. Furthermore, the increased use of laparoscopic procedures by patients is expected to fuel the global surgical stapling devices market during the forecast period. Laparoscopic operations are becoming more common because of their smaller incisions, lower expenses, and shorter hospital stays. Furthermore, manufacturers of surgical stapling devices engage continuously in research and development in order to design, develop, and launch technologically innovative items as well as improve their existing product portfolios in order to maintain their market position.
The adoption of surgical stapling devices by healthcare professionals has been heavily impacted by technological advances in surgical staples and associated staples. The major players are focusing on reducing the breadth of the surgical stapling device to facilitate both internal and external wound closure. Furthermore, the flexibility to modify the size and angle of the device's nobs allows the medical practitioner to easily perform laparoscopic surgeries.
With the introduction of powered surgical stapling equipment, the time necessary to close the incision following surgery has decreased, resulting in less blood loss and complications. Furthermore, it enables the surgeon to reduce pressure during wound closure. The powered surgical stapling equipment, for example, benefits the patient during trauma injuries where rapid wound closure is required to decrease blood loss. In clinical testing, the powered surgical stapler outperformed in terms of healing time and pain reduction. These technological advantages offered by surgical stapling devices are expected to drive market growth.
Browse for report at : https://www.acutemarketreports.com/report/surgical-stapling-devices-market
The key factors limiting market expansion are injury from removing stapler pins from the skin, functional failure during stapling, and the high cost of stapling equipment. There is a specific process for removing skin staplers used to seal a wound. This method often causes some harm to the wound or surgical site on the skin, which is projected to impede the global market's growth. Over 41,000 adverse event reports using surgical staplers designed for internal use were received by the US Food and Drug Administration in March 2019. Approximately 366 of the 41 000 cases resulted in death, necessitating an evaluation of these surgical staplers. There have been several reports of staplers failing to correctly fire the stapler pin into tissue. The primary cause of the erroneous firing of the stapling pin was thought to be defective stapling equipment. Many similar incidents have resulted in the gadgets malfunctioning, causing the operating surgeon difficulty. Furthermore, the rising cost of stapling devices is expected to stymie global market growth. These devices are around three times the price of the premium suturing materials now on the market. This is also expected to limit market expansion.
The powered surgical stapling device segment maintained the greatest market share of 63% in 2021, expanding at a rapid pace due to rising demand for upgraded technology. Powered staplers provide a number of advantages over manual staplers, including the convenience of use, a lower risk of problems such as blood loss and leakage, quicker operating times, and lower hospital expenses, which are driving this segment's growth. Because of factors such as technical advances, product launches, and firms' increasing focus on developing powered stapling devices, the market for powered stapling devices is predicted to grow at a faster CAGR. Furthermore, the advantages offered by powered stapling devices over manual staplers are expected to drive the expansion of this market segment.
The disposable surgical stapling device category will account for 68% of market revenue in 2021. Because of increased concerns about infectious diseases, the disposable category is expected to grow significantly in the future years. Disposable staplers are common because they lower the danger of infection during surgical procedures, therefore enhancing technical quality. Surgical staplers can also be discarded to limit the spread of infections from patients to healthcare personnel. Furthermore, the benefits of disposable staplers, such as lower infection risk and superior product selections, are expected to drive demand for this market segment. The reusable surgical stapling devices category is expected to grow at a slower CAGR than disposable staplers due to a higher risk of infection and a lower adoption rate in established markets. Because of the product's low cost, it is expected that the segment's share will be higher in developing countries than in developed countries.
In 2021, the curved category accounted for 49.5% of the entire surgical stapling instruments market. Curved stapling devices are the most commonly used because they have an excellent path through tissue and require less space for turning than straight stapling varieties. These staples have been meticulously manufactured to ensure outstanding performance and uniform stress distribution. As a result of the benefits of curved-type stapling, which allows for less surgical trauma, demand for the segment is expected to rise.
The general surgery segment is expected to provide the maximum revenue to the surgical stapling devices market during the forecast period. The extensive use and use of surgical staplers in a variety of general procedures have contributed to the segment's domination of the global surgical staplers market, which is likely to grow at a faster CAGR during the forecast period. Gynecological operations held a significant market share in 2021, closely followed by urological procedures. This surge in gynecological and urological operations is expected to boost this market segment in the near future.
The surgical stapling system market is divided into open surgery and laparoscopic surgery. Open surgery produced the most revenue for the surgical staplers market in 2021. The growth of open surgery is predicted to be slower than that of laparoscopic surgery. This pattern can be attributed to the increasing usage of laparoscopic surgeries to treat disease indications. Furthermore, major firms are focusing on the launch of laparoscopic staplers. The da Vinci series of laparoscopic surgical staplers from Intuitive Surgical, for example, have been technologically updated to reduce staple misfires, lowering surgical complications.
The hospital sector is expected to have the biggest market share (67% in 2021) and to increase at a quick pace during the forecast period. Because of the rising adoption of surgical equipment by hospitals, the hospital sector is expected to dominate the market. Furthermore, advances such as the rising use of robotic technology in surgery, which improves the outcomes of minimally invasive treatments, are expected to propel the category forward. Furthermore, favorable reimbursement policies for bariatric surgery will help the hospital segment continue its dominance. The hospital segment is expected to grow at a faster rate throughout the projection period due to increased product uptake in emerging regions. Specialist clinics, on the other hand, finished second in the global surgical staplers market due to better acceptance in major nations such as the United States, Germany, and Japan.
In 2021, North America made the most revenue of any region on the planet. The increasing use of technologically advanced laparoscopic surgical staplers, as well as the growing popularity of surgical robots that utilize powered stapling devices, will drive market expansion in the region. Furthermore, leading firms' increased proclivity to offer innovative surgical stapler products in North America is expected to fuel the market for surgical stapling devices in North America throughout the forecast period. By 2021, the United States would account for 85% of the North American surgical stapling equipment market. The growing elderly population, expanding surgical operations, and rising demand for improved medical technology all present significant prospects for the surgical stapling devices market in the United States. According to a recent National Centre for Health Statistics estimate, approximately 50 million surgical procedures are conducted in the United States each year. Furthermore, the country's high obesity rate and the growing number of FDA approvals for non-invasive procedures are expected to contribute to market expansion. Furthermore, top rivals are concentrating on inorganic growth tactics such as partnerships and collaborations, as well as new product launches in the United States, which are projected to fuel market demand.
During the projection period of 2023 to 2030, the Asia-Pacific region is expected to exhibit the highest market growth in terms of value. The rising competition among enterprises to capture the fast-emerging markets of China and India is expected to act as a market driver in the region. Furthermore, Chinese manufacturers' strategic planning to enter the Indian market is expected to stimulate market expansion in the country. However, a lack of trained labor and unemployment may stymie regional market growth. The market for surgical stapling devices in China is expected to grow at a CAGR of 10% during the projected period, owing to rising healthcare awareness and the need for novel medical technology. Furthermore, rising healthcare expenditures in China, an increase in the number of surgical procedures, and a growing older population are expected to drive market expansion in the coming years. Furthermore, the Chinese healthcare system supports the use of domestically manufactured medical devices while partially reimbursing foreign-made medical devices. This has boosted the production and use of Chinese-made medical devices, resulting in a significant number of Chinese medical device manufacturers. As a result, the Chinese market is expanding.
The surgical stapling device industry is highly consolidated, with the top two companies controlling a sizable market share. In terms of sales, Medtronic and Johnson and Johnson Services, Inc. control more than half of the market. This is owing to their extensive distribution networks and market penetration in new markets. Purple Surgical, 3M, Intuitive Surgical, B. Braun Melsungen AG, AesDex, LLC, and Others, in addition to Smith & Nephew, are prominent industry competitors in the worldwide surgical stapler market. Key players in the global market for surgical stapling devices are focusing on emerging markets to increase market share and user base through exclusive product release and approval. As an example,
Across October 2021, Medtronic plc announced that the HugoTM robotic-assisted surgery (RAS) system had received CE (ConformitéEuropéenne) Mark, allowing it to be distributed in Europe. CE Mark approval is for urologic and gynecologic treatments, which account for over half of all robotic procedures performed today.
3M announced the availability of the PREVENA RESTOR AXIO•FORMTM Incision Management System in October 2020, which is meant to maintain post-operative incisions and the surrounding soft tissue envelope after orthopedic surgical repair of lower extremity fractures.
